News
Current position:Product Center > Antibodies > Biosimilar Antibodies > Anti-CEACAM5 hIgG1 Reference Antibody (Labbio)
Anti-CEACAM5 hIgG1 Reference Antibody (Labbio)
Product Info

Cat. No:GM-87813MAB

Product:Anti-CEACAM5 hIgG1 Reference Antibody (Labbio)

Cat.No.&Size

GM-87813MAB-1mg / 1 mg

GM-87813MAB-5mg / 5 mg

GM-87813MAB-25mg / 25 mg

GM-87813MAB-50mg / 50 mg

GM-87813MAB-100mg / 100mg


Description

Expression System      CHO

Aggregation                < 5% as determined by SEC-HPLC

Purity                           > 95% as determined by SDS-PAGE

Endotoxin                    < 1 EU/mg, determined by LAL gel clotting assay

Sterility                        0.2 μm Filtered

Target                          CEACAM5

Clone                           Labetuzumab

Alternative Names     CD66e, CEACAM5; CEA

Source/Isotype           Human IgG1(REEM), Kappa

Application                 /

Description                 Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) also known as CD66e (Cluster of Differentiation 66e), is a member of the carcinoembryonic antigen (CEA) gene family. This gene encodes a cell surface glycoprotein that represents the founding member of the carcinoembryonic antigen (CEA) family of proteins. The encoded protein is used as a clinical biomarker for gastrointestinal cancers and may promote tumor development through its role as a cell adhesion molecule. Additionally, the encoded protein may regulate differentiation, apoptosis, and cell polarity. This gene is present in a CEA family gene cluster on chromosome 19. Alternative splicing results in multiple transcript variants.

Formulation                phosphate-buffered solution, pH 7.4.



Data

image.png

image.png

Current position:Product Center > -- > Anti-CEACAM5 hIgG1 Reference Antibody (Labbio)
classify
Anti-CEACAM5 hIgG1 Reference Antibody (Labbio)
Product Info

Cat. No:GM-87813MAB

Product:Anti-CEACAM5 hIgG1 Reference Antibody (Labbio)

Cat.No.&Size

GM-87813MAB-1mg / 1 mg

GM-87813MAB-5mg / 5 mg

GM-87813MAB-25mg / 25 mg

GM-87813MAB-50mg / 50 mg

GM-87813MAB-100mg / 100mg


Description

Expression System      CHO

Aggregation                < 5% as determined by SEC-HPLC

Purity                           > 95% as determined by SDS-PAGE

Endotoxin                    < 1 EU/mg, determined by LAL gel clotting assay

Sterility                        0.2 μm Filtered

Target                          CEACAM5

Clone                           Labetuzumab

Alternative Names     CD66e, CEACAM5; CEA

Source/Isotype           Human IgG1(REEM), Kappa

Application                 /

Description                 Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) also known as CD66e (Cluster of Differentiation 66e), is a member of the carcinoembryonic antigen (CEA) gene family. This gene encodes a cell surface glycoprotein that represents the founding member of the carcinoembryonic antigen (CEA) family of proteins. The encoded protein is used as a clinical biomarker for gastrointestinal cancers and may promote tumor development through its role as a cell adhesion molecule. Additionally, the encoded protein may regulate differentiation, apoptosis, and cell polarity. This gene is present in a CEA family gene cluster on chromosome 19. Alternative splicing results in multiple transcript variants.

Formulation                phosphate-buffered solution, pH 7.4.



Data

image.png

image.png

Tel: 400-627-9288
Message consultation
reset
submit
Service
WhatApp
Phone
Message
Message consultation
reset
submit